Wen Du

Title: Innovations of Wen Du in Pharmaceutical Research

Introduction

Wen Du is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, his work focuses on addressing critical health issues, such as diabetes.

Latest Patents

Wen Du's latest patents include a phenyl C-glucoside derivative containing a deoxyglucose structure. This invention provides a preparation method and various uses, particularly in the formulation of medicaments for treating diabetes. The patent outlines a method for synthesizing this derivative, which is characterized by its simplicity and cost-effectiveness, making it suitable for large-scale industrial production. Additionally, the invention includes a cocrystal of (1S)-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1,6-dideoxy-D-glucose and L-proline, along with its preparation method and applications.

Career Highlights

Wen Du is affiliated with the Tianjin Institute of Pharmaceutical Research, where he conducts his research and development activities. His work has been instrumental in advancing pharmaceutical sciences and improving treatment options for various diseases.

Collaborations

Wen Du collaborates with several esteemed colleagues, including Guilong Zhao and Yuli Wang, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Wen Du's contributions to pharmaceutical research exemplify the impact of innovation in medicine. His patents reflect a commitment to developing effective treatments for diabetes, showcasing the importance of research in improving health outcomes.